XYPHOS

Serial Number 98280623
Registration 8005886
700

Registration Progress

Application Filed
Nov 21, 2023
Under Examination
Mar 4, 2025
Approved for Publication
Jan 7, 2025
Published for Opposition
Jan 7, 2025
Registered
Oct 28, 2025

Trademark Image

XYPHOS

Basic Information

Serial Number
98280623
Registration Number
8005886
Filing Date
November 21, 2023
Registration Date
October 28, 2025
Published for Opposition
January 7, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 28, 2025
Registration
Registered
Classes
005

Rights Holder

Xyphos Biosciences, Inc.

03
Address
100 Kimball Way
South San Francisco, CA 94080

Ownership History

Xyphos Biosciences, Inc.

Original Applicant
03
South San Francisco, CA

Xyphos Biosciences, Inc.

Owner at Publication
03
South San Francisco, CA

Xyphos Biosciences, Inc.

Original Registrant
03
South San Francisco, CA

Legal Representation

Attorney
Christopher Bolinger

USPTO Deadlines

Next Deadline
2114 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251028)
Due Date
October 28, 2031
Grace Period Ends
April 28, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description Documents
Oct 28, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 28, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 4, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 4, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 2, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 20, 2025 IUAF S USE AMENDMENT FILED Loading...
Oct 2, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 20, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 20, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 20, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 20, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 20, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 5, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 14, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 14, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 14, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 14, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 14, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 4, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 7, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 7, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 1, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 22, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 21, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 21, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 21, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 21, 2024 ALIE A ASSIGNED TO LIE Loading...
Jul 9, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jul 9, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 9, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 9, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 26, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 25, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 25, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 25, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 24, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 9, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 24, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biological preparations for treatment of cancer and viral-infected cells; pharmaceuticals in the nature of biologic agents for adoptive cellular therapy
First Use Anywhere: May 21, 2024
First Use in Commerce: May 21, 2024

Classification

International Classes
005